Hasna Kazi, Lin Li, Samantha J Ellis, John R Zalcberg, Charles H C Pilgrim
{"title":"常规记叙式CT报告是否能提供足够的信息以适当分期胰腺癌?","authors":"Hasna Kazi, Lin Li, Samantha J Ellis, John R Zalcberg, Charles H C Pilgrim","doi":"10.1016/j.hpb.2025.05.001","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pancreatic ductal adenocarcinoma (PDAC) is staged using CT imaging generally reported in a narrative prose style, which can omit key details critical for an operating surgeon. This study assessed sixty-three potential radiological descriptors derived from the International Consensus Guidelines (ICG) to classify the resectability status of PDAC to determine whether reports adequately staged PDAC.</p><p><strong>Methods: </strong>150 CT reports from patients with confirmed PDAC were collected from 19 hospitals across Australia (July-December 2023), as part of the SCANPatient trial. Reports were evaluated based on how many of the 63 relevant features were addressed.</p><p><strong>Results: </strong>Less than half all relevant fields were appropriately addressed in prose reports (41.1 %, 10.7 of an average 26 relevant fields, as not all fields were relevant for each case). Less than 35 % of reports adequately addressed the tumour-vessel relationship with the superior mesenteric artery and vein. The coeliac artery was addressed in just 30 reports (20 %), and non-standard and vague terminology was common.</p><p><strong>Conclusion: </strong>Prose CT reporting for PDAC resectability in Australia does not specifically address many important features determining resectability. Prose reporting is associated with high rates of omission of relevant negatives as well as some errors of commission and considerable language variability.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Do routine narrative style CT reports provide sufficient information to adequately stage pancreatic cancer.\",\"authors\":\"Hasna Kazi, Lin Li, Samantha J Ellis, John R Zalcberg, Charles H C Pilgrim\",\"doi\":\"10.1016/j.hpb.2025.05.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pancreatic ductal adenocarcinoma (PDAC) is staged using CT imaging generally reported in a narrative prose style, which can omit key details critical for an operating surgeon. This study assessed sixty-three potential radiological descriptors derived from the International Consensus Guidelines (ICG) to classify the resectability status of PDAC to determine whether reports adequately staged PDAC.</p><p><strong>Methods: </strong>150 CT reports from patients with confirmed PDAC were collected from 19 hospitals across Australia (July-December 2023), as part of the SCANPatient trial. Reports were evaluated based on how many of the 63 relevant features were addressed.</p><p><strong>Results: </strong>Less than half all relevant fields were appropriately addressed in prose reports (41.1 %, 10.7 of an average 26 relevant fields, as not all fields were relevant for each case). Less than 35 % of reports adequately addressed the tumour-vessel relationship with the superior mesenteric artery and vein. The coeliac artery was addressed in just 30 reports (20 %), and non-standard and vague terminology was common.</p><p><strong>Conclusion: </strong>Prose CT reporting for PDAC resectability in Australia does not specifically address many important features determining resectability. Prose reporting is associated with high rates of omission of relevant negatives as well as some errors of commission and considerable language variability.</p>\",\"PeriodicalId\":13229,\"journal\":{\"name\":\"Hpb\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hpb\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.hpb.2025.05.001\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hpb","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hpb.2025.05.001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Do routine narrative style CT reports provide sufficient information to adequately stage pancreatic cancer.
Background: Pancreatic ductal adenocarcinoma (PDAC) is staged using CT imaging generally reported in a narrative prose style, which can omit key details critical for an operating surgeon. This study assessed sixty-three potential radiological descriptors derived from the International Consensus Guidelines (ICG) to classify the resectability status of PDAC to determine whether reports adequately staged PDAC.
Methods: 150 CT reports from patients with confirmed PDAC were collected from 19 hospitals across Australia (July-December 2023), as part of the SCANPatient trial. Reports were evaluated based on how many of the 63 relevant features were addressed.
Results: Less than half all relevant fields were appropriately addressed in prose reports (41.1 %, 10.7 of an average 26 relevant fields, as not all fields were relevant for each case). Less than 35 % of reports adequately addressed the tumour-vessel relationship with the superior mesenteric artery and vein. The coeliac artery was addressed in just 30 reports (20 %), and non-standard and vague terminology was common.
Conclusion: Prose CT reporting for PDAC resectability in Australia does not specifically address many important features determining resectability. Prose reporting is associated with high rates of omission of relevant negatives as well as some errors of commission and considerable language variability.
期刊介绍:
HPB is an international forum for clinical, scientific and educational communication.
Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.
Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.
HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.
Abstracted and Indexed in:
MEDLINE®
EMBASE
PubMed
Science Citation Index Expanded
Academic Search (EBSCO)
HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).